ADAMTS5 and Duchenne muscular dystrophy: More importantly, the observed therapeutic benefits of ADAMTS-5 blockade in EDL muscles from mdx mice are of pathophysiological and translational relevance, as in DMD it is the fast muscle fibers which are preferentially vulnerable to degeneration [58].